DK1299541T3 - Fremgangsmåde til udvinding og anvendelse af nye humane defensiner som biologisk aktive proteiner til behandling af infektioner og andre sygdomme - Google Patents

Fremgangsmåde til udvinding og anvendelse af nye humane defensiner som biologisk aktive proteiner til behandling af infektioner og andre sygdomme

Info

Publication number
DK1299541T3
DK1299541T3 DK01969365T DK01969365T DK1299541T3 DK 1299541 T3 DK1299541 T3 DK 1299541T3 DK 01969365 T DK01969365 T DK 01969365T DK 01969365 T DK01969365 T DK 01969365T DK 1299541 T3 DK1299541 T3 DK 1299541T3
Authority
DK
Denmark
Prior art keywords
fragments
derivatives
diseases
extraction
biologically active
Prior art date
Application number
DK01969365T
Other languages
English (en)
Inventor
Wolf-Georg Forssmann
Jose-Ramon Conejo-Garcia
Knut Adermann
Original Assignee
Ipf Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipf Pharmaceuticals Gmbh filed Critical Ipf Pharmaceuticals Gmbh
Application granted granted Critical
Publication of DK1299541T3 publication Critical patent/DK1299541T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK01969365T 2000-07-11 2001-07-11 Fremgangsmåde til udvinding og anvendelse af nye humane defensiner som biologisk aktive proteiner til behandling af infektioner og andre sygdomme DK1299541T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10033505 2000-07-11
PCT/EP2001/007973 WO2002004487A2 (de) 2000-07-11 2001-07-11 Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen

Publications (1)

Publication Number Publication Date
DK1299541T3 true DK1299541T3 (da) 2008-01-21

Family

ID=7648436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01969365T DK1299541T3 (da) 2000-07-11 2001-07-11 Fremgangsmåde til udvinding og anvendelse af nye humane defensiner som biologisk aktive proteiner til behandling af infektioner og andre sygdomme

Country Status (11)

Country Link
US (2) US20040116652A1 (da)
EP (2) EP1299541B1 (da)
JP (1) JP2004504017A (da)
AT (1) ATE373091T1 (da)
AU (1) AU2001289641A1 (da)
CA (1) CA2427066A1 (da)
DE (1) DE50113010D1 (da)
DK (1) DK1299541T3 (da)
ES (1) ES2197840T3 (da)
PT (1) PT1299541E (da)
WO (1) WO2002004487A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576755B1 (en) 1997-09-10 2003-06-10 Zymogenetics, Inc. Beta-defensins
EP1878794A3 (en) * 1999-11-30 2008-01-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2001092309A2 (en) * 2000-06-01 2001-12-06 University Of Iowa Research Foundation Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
AU2002227925A1 (en) * 2000-11-14 2002-05-27 Ipf Pharmaceuticals Gmbh Human beta-defensin-3
MXPA05006359A (es) * 2002-12-19 2006-02-08 Yitzchak Hillman Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos.
GB0300718D0 (en) 2003-01-13 2003-02-12 Ares Trading Sa Proteins
FR2879203A1 (fr) * 2004-12-09 2006-06-16 Univ Rennes I Etablissement Pu Peptides antimicrobiens, polypeptides comprenant lesdits peptides, procedes pour les preparer, genes codant pour lesdits peptides, vecteurs, organismes transformes et compositions les contenant
US8202835B2 (en) 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
US9044438B2 (en) 2005-06-17 2015-06-02 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
GB0514482D0 (en) * 2005-07-14 2005-08-17 Ares Trading Sa Protein
CN102198264B (zh) * 2010-03-23 2013-10-09 中国科学院上海生命科学研究院 大鼠附睾特异抗菌肽β-防御素15及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1012285B1 (en) * 1997-09-10 2005-08-03 ZymoGenetics, Inc. Beta-defensins
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
CA2371794C (en) * 1999-02-01 2013-10-29 Enno Christophers Human antibiotic proteins
US20040072777A1 (en) * 2000-01-05 2004-04-15 Otto Froelich Epididymal antimicrobial peptides

Also Published As

Publication number Publication date
AU2001289641A1 (en) 2002-01-21
WO2002004487A3 (de) 2002-09-19
ATE373091T1 (de) 2007-09-15
CA2427066A1 (en) 2003-02-24
US20090124541A1 (en) 2009-05-14
ES2197840T3 (es) 2008-03-16
EP1299541A2 (de) 2003-04-09
EP1887015A3 (de) 2008-05-07
EP1887015A2 (de) 2008-02-13
WO2002004487A2 (de) 2002-01-17
PT1299541E (pt) 2007-10-01
ES2197840T1 (es) 2004-01-16
EP1299541B1 (de) 2007-09-12
US20040116652A1 (en) 2004-06-17
JP2004504017A (ja) 2004-02-12
DE50113010D1 (de) 2007-10-25

Similar Documents

Publication Publication Date Title
Tam et al. An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides
KR100891157B1 (ko) 짧은 생물활성 펩티드 및 그것들의 사용 방법
DK1299541T3 (da) Fremgangsmåde til udvinding og anvendelse af nye humane defensiner som biologisk aktive proteiner til behandling af infektioner og andre sygdomme
Casciaro et al. Promising approaches to optimize the biological properties of the antimicrobial peptide esculentin-1a (1–21) NH2: amino acids substitution and conjugation to nanoparticles
ES2784484T3 (es) Péptido antimicrobiano
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
Casciaro et al. The Potential of frog skin peptides for anti-Infective therapies: the Case of Esculentin-1a (1-21) NH2
ATE349538T1 (de) Collectin-komplement aktivierende proteinchimären
Chen et al. Purification and characterization of an antibacterial and anti-inflammatory polypeptide from Arca subcrenata
TR201815301T4 (tr) Antimikrobiyal peptit ve bunun kullanımları.
RU2005127076A (ru) Пептидные ингибиторы токсинов, производные ll-37
CN101679495A (zh) 用于细胞学和免疫学调节的短的生物活性肽
US20150218233A1 (en) Synthetic pntx(19) peptide, pharmaceutical compositions and use
CY1105105T1 (el) Χρηση του διστροντιου αλατος του 2-[ν,ν-δι(καρβοξυμεξυλ) amino]- 3-κυανο-4-καρβοξυμεθυλ-θειοφενο-5-καρβοξυλικου οξεος για τη ληψη φαρμακων που προοριζονται για τη θεραπεια γαστρο-δωδεκαδακτυλικων πονων
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных
Schröder et al. Antimicrobial peptides in skin disease
KR20130109544A (ko) 전복 유래의 새로운 항미생물성 펩타이드 및 이의 용도
AR013886A1 (es) Proteinas utiles para tratar la obesidad y condiciones asociadas con la obesidad; composiciones farmaceuticas formuladas con dichas proteinas;compuestos polinucleoticos de dna que codifican dichas proteinas y procedimiento para pepararlas
KR20220044947A (ko) 진균 감염의 치료를 위한 조성물 및 방법(compositions and methods for treatment of fungal infections)
Depta et al. Wysoki nska
KR20140087664A (ko) 가다랑어 간 유래의 새로운 항미생물성 펩타이드 및 이의 용도
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
ATE544779T1 (de) Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten
ES2199098T1 (es) Metodo para la extraccion y uso de peptidos que son activos como antibioticos para tratar enfermedades infecciosas.